All Fields
Computer Science
Medicine
FAQ
Contact
Sign in
DYRK1B gene
Known as:
dual specificity tyrosine phosphorylation regulated kinase 1B
, DUAL-SPECIFICITY TYROSINE PHOSPHORYLATION-REGULATED KINASE 1B
, DYRK1B
Â
(More)
Â
Topic mentions per year
Topic mentions per year
1993-2017
0
2
4
6
1993
2017
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Iron-induced oxidative stress activates AKT and ERK1/2 and decreases Dyrk1B and PRMT1 in neuroblastoma SH-SY5Y cells.
Elizabeth Bautista
,
Paula M. Vergara
,
José Segovia
Journal of trace elements in medicine and biology…
2016
Iron is essential for proper neuronal functioning; however, excessive accumulation of brain iron is reported in Parkinson's…Â
(More)
Is this relevant?
2016
2016
DYRK1B as therapeutic target in Hedgehog/GLI-dependent cancer cells with Smoothened inhibitor resistance.
Wolfgang Gruber
,
Martin Hutzinger
,
+9 authors
Fritz Aberger
Oncotarget
2016
A wide range of human malignancies displays aberrant activation of Hedgehog (HH)/GLI signaling, including cancers of the skin…Â
(More)
Is this relevant?
2015
2015
The Tumor Suppressor NKX3.1 Is Targeted for Degradation by DYRK1B Kinase.
Liang-Nian Song
,
José Silva
,
Antonius A Koller
,
Andrew S. Rosenthal
,
Emily I. Chen
,
Edward P. Gelmann
Molecular cancer research : MCR
2015
UNLABELLED NKX3.1 is a prostate-specific homeodomain protein and tumor suppressor whose expression is reduced in the earliest…Â
(More)
Is this relevant?
2015
2015
Role of dual specificity tyrosine-phosphorylation-regulated kinase 1B (Dyrk1B) in S-phase entry of HPV E7 expressing cells from quiescence.
Na Zhou
,
Shoudao Yuan
,
Rongchun Wang
,
Weifang Zhang
,
Jason J. Chen
Oncotarget
2015
The high-risk human papillomavirus (HPV) is the causative agent for cervical cancer. The HPV E7 oncogene promotes S-phase entry…Â
(More)
Is this relevant?
2015
2015
Identification of DYRK1B as a substrate of ERK1/2 and characterisation of the kinase activity of DYRK1B mutants from cancer and metabolic syndrome
Anne L. Ashford
,
Tom P. J. Dunkley
,
+10 authors
Simon J Cook
Cellular and Molecular Life Sciences
2015
The dual-specificity tyrosine-phosphorylation-regulated kinase, DYRK1B, is expressed de novo during myogenesis, amplified or…Â
(More)
Is this relevant?
2014
2014
A novel DYRK1B inhibitor AZ191 demonstrates that DYRK1B acts independently of GSK3β to phosphorylate cyclin D1 at Thr(286), not Thr(288).
Anne L. Ashford
,
David Oxley
,
+4 authors
Pamela A. Lochhead
The Biochemical journal
2014
DYRK1B (dual-specificity tyrosine phosphorylation-regulated kinase 1B) is amplified in certain cancers and may be an oncogene…Â
(More)
Is this relevant?
2011
2011
A K+ channel from salt-tolerant melon inhibited by Na+.
Yi-dong Zhang
,
Anne-Aliénor Véry
,
Li-Min Wang
,
Yang-Wu Deng
,
Hervé Sentenac
,
Dan-Feng Huang
The New phytologist
2011
• The possible roles of K(+) channels in plant adaptation to high Na(+) conditions have not been extensively analyzed. Here, we…Â
(More)
Is this relevant?
Highly Cited
2009
Highly Cited
2009
Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation.
Nora Göckler
,
Guillermo F Jofré
,
C. K. Papadopoulos
,
Ulf Soppa
,
Francisco Javier Tejedor Tejedor
,
Walter Becker
The FEBS journal
2009
DYRK1A is a dual-specificity protein kinase that autophosphorylates a conserved tyrosine residue in the activation loop but…Â
(More)
Is this relevant?
1999
1999
Cloning and characterization of DYRK1B, a novel member of the DYRK family of protein kinases.
Steven B. Leder
,
Y. Weber
,
Xavier Altafaj
,
Xavier Estivill
,
H. G. Joost
,
W F Becker
Biochemical and biophysical research…
1999
The DYRK1A gene on human chromosome 21 encodes a protein kinase presumed to be involved in the pathogenesis of mental retardation…Â
(More)
Is this relevant?
1993
1993
A Runge - Kutta Type Boundary Value ODE Solverwith Defect
W. H. Enright
,
Paul R Muir
1993
A popular approach for the numerical solution of boundary value ODE problems involves the use of collocation methods. Such…Â
(More)
Is this relevant?